Marksans Pharma Limited (MARKSANS.BO)
INR 314.2
(-2.1%)
INR 314.2
(-2.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 21.77 Billion | 18.49 Billion | 14.8 Billion | 13.68 Billion | 11.29 Billion | 9.87 Billion |
| Cost of Revenue | 14.06 Billion | 9.21 Billion | 7.16 Billion | 6.18 Billion | 5.91 Billion | 5.17 Billion |
| Gross Profit | 7.71 Billion | 9.28 Billion | 7.63 Billion | 7.49 Billion | 5.38 Billion | 4.69 Billion |
| Operating Expenses | 3.28 Billion | 6.15 Billion | 5.46 Billion | 4.31 Billion | 3.72 Billion | 3.6 Billion |
| Selling, General and Administrative Expenses | 3.05 Billion | 1.18 Billion | 1.33 Billion | 1.33 Billion | 972.25 Million | 898.35 Million |
| Research and Development Expenses | 230.6 Million | 148.97 Million | 297.89 Million | 127.49 Million | 83.14 Million | 57.12 Million |
| Other Expenses | - | 74.93 Million | 95.62 Million | 38.73 Million | 1.5 Million | 903.62 Thousand |
| Cost and Expenses | 13.98 Billion | 15.36 Billion | 12.63 Billion | 10.49 Billion | 9.63 Billion | 8.77 Billion |
| Operating Income | 7.79 Billion | 2.99 Billion | 2.06 Billion | 2.98 Billion | 1.61 Billion | 979.08 Million |
| Interest Expense | 112.03 Million | 57.46 Million | 53.9 Million | 34.67 Million | 49.7 Million | 59.24 Million |
| Income Tax Expense | 1.08 Billion | 723.32 Million | 606.97 Million | 636.26 Million | 364.19 Million | 238.69 Million |
| Earnings before Tax | 4.23 Billion | 3.37 Billion | 2.47 Billion | 3.02 Billion | 1.57 Billion | 1.04 Billion |
| Net Income | 3.13 Billion | 2.66 Billion | 1.84 Billion | 2.38 Billion | 1.2 Billion | 804.37 Million |
| Earnings Per Share Basic | 6.92 | 6.41 | 4.51 | 5.76 | 2.86 | 1.97 |
| Earnings Per Share Diluted | 6.92 | 6.41 | 4.51 | 5.76 | 2.86 | 1.97 |
| Weighted Average Shares Outstanding | 453.32 Million | 415.4 Million | 409.31 Million | 409.31 Million | 409.31 Million | 409.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 453.16 Million | 415.4 Million | 409.31 Million | 409.31 Million | 409.31 Million | 409.31 Million |
| Gross Margin | 0.35 | 0.50 | 0.52 | 0.55 | 0.48 | 0.48 |
| EBIT Margin | 0.21 | 0.23 | 0.20 | 0.26 | 0.17 | 0.13 |
| Profit Margin | 0.14 | 0.14 | 0.12 | 0.17 | 0.11 | 0.08 |
| EBITDA | 4.58 Billion | 3.98 Billion | 3 Billion | 3.46 Billion | 1.92 Billion | 1.36 Billion |
| Earnings Before Tax Margin | 0.36 | 0.16 | 0.14 | 0.22 | 0.14 | 0.10 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 5.9 Billion | 21.77 Billion | 5.6 Billion | 5.86 Billion | 5.31 Billion | 5 Billion |
| Cost of Revenue | 3.62 Billion | 14.06 Billion | 3.7 Billion | 2.72 Billion | 2.52 Billion | 2.42 Billion |
| Gross Profit | 2.27 Billion | 7.71 Billion | 1.89 Billion | 3.13 Billion | 2.78 Billion | 2.57 Billion |
| Operating Expenses | 1.19 Billion | 3.87 Billion | 1 Billion | 2.02 Billion | 1.82 Billion | 1.68 Billion |
| Selling, General and Administrative Expenses | 1.19 Billion | - | 1 Billion | 932.6 Million | 934.39 Million | 870.69 Million |
| Research and Development Expenses | - | - | - | 125 Million | - | - |
| Other Expenses | 149.49 Million | 504.22 Million | 165.3 Million | 48 Million | 189.96 Million | 100.96 Million |
| Cost and Expenses | 4.82 Billion | 17.93 Billion | 4.71 Billion | 4.75 Billion | 4.34 Billion | 4.11 Billion |
| Operating Income | 1.07 Billion | 3.84 Billion | 885.87 Million | 1.15 Billion | 963.98 Million | 883.06 Million |
| Interest Expense | 29.24 Million | 112.03 Million | 48.41 Million | 31.61 Million | 16.26 Million | 15.76 Million |
| Income Tax Expense | 309.51 Million | 1.08 Billion | 226.32 Million | 296.93 Million | 299.18 Million | 263.88 Million |
| Earnings before Tax | 1.2 Billion | 4.23 Billion | 1 Billion | 1.12 Billion | 1.13 Billion | 968.26 Million |
| Net Income | 887.52 Million | 3.13 Billion | 782.89 Million | 832.35 Million | 835.18 Million | 686.58 Million |
| Earnings Per Share Basic | 1.96 | - | 1.73 | 1.84 | 1.84 | 1.52 |
| Earnings Per Share Diluted | 1.96 | - | 1.73 | 1.84 | 1.84 | 1.52 |
| Weighted Average Shares Outstanding | 453.16 Million | 453.16 Million | 453.16 Million | 453.16 Million | 453.16 Million | 453.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 453.16 Million | 453.16 Million | 453.16 Million | 453.16 Million | 453.16 Million | 453.16 Million |
| Gross Margin | 0.39 | 0.35 | 0.34 | 0.53 | 0.52 | 0.51 |
| EBIT Margin | 0.22 | - | 0.20 | 0.24 | 0.25 | 0.22 |
| Profit Margin | 0.15 | 0.14 | 0.14 | 0.14 | 0.16 | 0.14 |
| EBITDA | 1.28 Billion | - | 1.09 Billion | 1.37 Billion | 1.32 Billion | 1.12 Billion |
| Earnings Before Tax Margin | 0.18 | 0.18 | 0.16 | 0.20 | 0.18 | 0.18 |
0QQG
300918
CVALF
0IQE
VIO
BLV